Locally advanced lung cancer treatment is entering a more promising era — but the specific study behind the headline was not provided Locally advanced lung cancer sits in one of the most difficult zones in oncology. In many cases, the disease is alre...
Read moreFor decades, heart disease was treated as a men’s problem. In women, the risk is different — and too often more overlooked For a long time, cardiovascular disease was presented to the public with a very specific image: a man, usually middle-aged or o...
Read moreCancer-linked mutations may alter the brain’s immune system in Alzheimer’s — but the effects do not appear to be uniformly harmful For decades, cancer and Alzheimer’s disease were treated as almost opposite biological stories. One was associated with...
Read moreA new pilot test is trying to measure why some cancer survivors feel physically drained — but the tool is still early-stage One of the most frustrating parts of cancer survivorship is that some of the hardest symptoms to live with are also the hardes...
Read moreA Western diet and binge drinking may hit the liver as a double insult — and together they may be worse than either alone For a long time, liver disease was often discussed in fairly separate boxes. On one side was alcohol. On the other were poor die...
Read moreExtreme climate events raise cardiovascular risk — and heat plus air pollution may be an especially dangerous mix For a long time, heatwaves, severe storms, and other extreme climate events were treated mainly as environmental, urban, or infrastructu...
Read moreA new KIR-CAR approach is trying to bring the engineered-cell revolution to solid tumours — but for now it looks more like a translational promise than a proven treatment In recent years, CAR-based cell therapies have helped reshape treatment for som...
Read moreA long-term study is revealing how some blood cancers evolve — and why certain diseases come back more aggressive One of the hardest questions in blood-cancer care has also been one of the most frightening for patients: why do some diseases seem quie...
Read moreKRAS G12D, once treated as an untouchable target, is finally starting to give way in lung cancer — but the breakthrough is still in progress Few stories in modern oncology have been shaped as much by frustration and persistence as the story of KRAS....
Read more
